RICARDO ANTONIO ESPINOSA ESCUDERO-rekin lankidetzan egindako argitalpenak (6)

2022

  1. Beneficial effect of ursodeoxycholic acid in patients with acyl-CoA oxidase 2 (ACOX2) deficiency–associated hypertransaminasemia

    Hepatology, Vol. 76, Núm. 5, pp. 1259-1274

  2. Impact of Liver Inflammation on Bile Acid Side Chain Shortening and Amidation

    Cells, Vol. 11, Núm. 24

2020

  1. Cellular mechanisms accounting for the refractoriness of colorectal carcinoma to pharmacological treatment

    Cancers, Vol. 12, Núm. 9, pp. 1-34

  2. Molecular bases of drug resistance in hepatocellular carcinoma

    Cancers, Vol. 12, Núm. 6, pp. 1-26

2019

  1. Pharmacogenetics of hepatocellular carcinoma and cholangiocarcinoma

    Cancer Drug Resistance, Vol. 2, Núm. 3, pp. 680-709

  2. Role of transportome in the pharmacogenomics of hepatocellular carcinoma and hepatobiliary cancer

    Pharmacogenomics, Vol. 20, Núm. 13, pp. 957-970